Updates ·
Health notices · Saturday 15 August
3 notices from the agencies today, in plain words, each with the original linked.
Sunny Pharmtech recalls cyclophosphamide injections due to particles
FDA-SAFETY
If you are using cyclophosphamide for injection from Sunny Pharmtech, you may be affected by a voluntary nationwide recall.
The recall is for three lots (1 g/vial and 2 g/vial) due to particulate matter identified as steel.
Sunny Pharmtech says there have been no adverse events or injuries reported so far.
Grand Central Bakery recalls potato sourdough over possible metal pieces
CDC · Food safety
The Centers for Disease Control and Prevention says Grand Central Bakery (Seattle, WA) is recalling some loaves of Potato Sourdough bread.
The recall is because the bread may contain pieces of metal (a foreign object).
If you have one of these loaves, don’t eat it and follow the recall instructions provided by the company or retailer.
What to do
- Follow the recall instructions for the Grand Central Bakery Potato Sourdough loaves due to possible metal pieces.
Class II drug safety issue reported for levothyroxine tablets
FDA · Recall
If you take levothyroxine sodium tablets, the US Food and Drug Administration reports a Class II drug safety issue for specific packaged strengths and sizes.
The product described is Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 100 tablets per carton, distributed nationwide in the USA.
The FDA class II designation means a health hazard is possible, though it is not described as immediately life-threatening in this notice.
Check your tablet packaging against the specific product details listed in the notice, and stop using it only if instructed by the recall information (if provided).
Where this comes from
- Sunny Pharmtech recalls cyclophosphamide injections due to particlesfda-safety
- Grand Central Bakery recalls potato sourdough over possible metal piecesCDC — food safety
- Class II drug safety issue reported for levothyroxine tabletsUS Food and Drug Administration — enforcement report
Each notice above is summarised from the agency's own publication, linked beside it. Nothing here is a finding of ours.